News
13m
Stockhead on MSNHealth Check: Cancer drug developers drive further positive Car-T results
Two of the leading developers of Car-T immuno-oncology drugs, Imugene and Chimeric have unveiled further positive trial ...
Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies ...
Lionel Messi exited Inter Miami’s Leagues Cup game against Necaxa in the 11th minute after a stretch of 30 games for Miami with 18 goals and nine assists.
If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...
Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...
Lionel Messi left injured in the 11th minute with hamstring discomfort, but Inter Miami earned a 5-4 penalty shootout win ...
Apple TV has had a 100% viewership increase during the first week of the 2025 Leagues Cup tournament compared to last year, ...
Upgraded Relay Therapeutics to a buy after valuation decline. Read more on RLAY's pipeline progress, financial health, and ...
These 10 stocks could mint the next wave of millionaires › Ocugen (NASDAQ:OCGN), a biotechnology company developing gene therapies and regenerative medicine solutions for eye diseases, released its ...
WICHITA, Kan. (KSNW) — The City of Wichita is moving ahead with the next phase of its downtown paid parking system.
A phase 3 trial of Spine BioPharma’s chronic low back pain candidate has missed its primary endpoint. But, with the biotech pinning the failure on a “very high sham control response,” management plans ...
Joseph Paintsil scores a pair of goals and Marco Reus adds another in the second half as the Galaxy get off to a strong start ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results